Plasmonics in conjunction with supramolecular chemistry brings new opportunities for biosensing. Modified with macrocyclic supramolecules, noble metal nanoparticles possess improved biocompatibility and highly efficient biomolecule immobilization and recognition via host-guest interaction. In this work, we synthesize high-quality and monodisperse β-cyclodextrin-capped gold nanoparticles (β-CD-capped AuNPs) in one-step facile and eco-friendly process, where β-CD functions as both reducing and capping agent. Integrated with a microfiber , the β-CD-capped AuNPs deliver promising localized surface plasmon resonance properties and ultralow detection limit of cholesterol molecules of 5 aM. The selective recognition of our proposed biosensor to cholesterol is further verified by interference study and analysis of real human serum samples. This study shows the bright prospects of supramolecular chemistry assisted plasmonics in achieving highly integrated and highly sensitive biosensing with extremely low consumption of clinical samples and small footprint.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2019) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: